Cancellation of state registration. Zipsil®

February 13, 2018
Active substances:
Trade names:
ICD-10:
V.F20-F29.F20    Schizophrenia
V.F20-F29.F21    Chrysotile disorder
V.F20-F29.F22    Chronic delusional disorders
V.F20-F29.F23    Acute and transient psychotic disorders
V.F20-F29.F25    Schizoaffective disorder
V.F20-F29.F29    Inorganic psychosis, unspecified
Zipsil, ziprasidone, schizophrenia, schizophrenia, schizotypic disorder, delusional disorders, schizoaffective disorder

Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Lawfrom 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to cancel the state registration and exclusion from the state register of medicines for medical use of the medicinal product (registration certificate LP-000210 dated February 15, 2011 issued by the Limited Liability Company "KRKA- RUS "(OOO" KRKA-RUS "), Russia):

Zipsil® (trade name of the medicinal product)

Ziprasidone (international non-proprietary or grouping or chemical name)

capsules, 20 mg, 40 mg, 60 mg, 80 mg (dosage form, dosage)

Limited Liability Company "KRKA-RUS" (LLC "KRKA-RUS"), Russia 143500, Moscow Region, Istra, ul. Moscow, d. 50 JSC "Krka, dd, Novo mesto", Slovenia Smarjeska cesta 6, 8501 Novo mesto, Slovenia (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing an application by the authorized legal entity LLC KRKA-RUS to cancel the state registration of the medicinal product.